Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 8,995,280	$ 8,410,489
General and administrative	8,506,438	12,268,909
Operating loss	(17,501,718)	(20,679,398)
Interest and other expense, net	(174,514)	(30,593)
Loss before income taxes	(17,676,232)	(20,709,991)
Income tax benefit (expense)
Net loss and Comprehensive loss	$ (17,676,232)	$ (20,709,991)
Net loss per share of common stock, basic and diluted	$ (1.56)	$ (2.79)
Weighted average number of shares used in computing net loss per share of common stock, basic and diluted	11,309,412	7,413,579